Clinical Significance of UDP-Glucuronosyltransferase 1A1*6 for Toxicities of Combination Chemotherapy with Irinotecan and Cisplatin in Gynecologic Cancers

Publisher： Karger

E-ISSN： 1423-0232|76|5|315-321

ISSN： 0030-2414

Source： Oncology, Vol.76, Iss.5, 2009-03, pp. : 315-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Chemotherapy of Cisplatin, Ifosfamide, and Irinotecan with rhG-CSF Support in Patients with Brain Metastases from Non-Small Cell Lung Cancer

By  

Oncology, Vol. 59, Iss. 4, 2000-11 ,pp. : 291-295

Karger

Access to resources Recommend Favorite

Irinotecan: New Results in the Combination Chemotherapy of Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 4, 2000-05 ,pp. : 8-14

Karger

Access to resources Recommend Favorite

Pilot Study of Combination Chemotherapy Using Irinotecan plus S-1 for Metastatic Pancreatic Cancer

By  

Oncology, Vol. 75, Iss. 1-2, 2008-08 ,pp. : 67-70

Karger

Access to resources Recommend Favorite

Irinotecan (CPT-11) and Cisplatin as First-Line Chemotherapy for Advanced Ovarian Cancer

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 16-22

Karger

Access to resources Recommend Favorite

Response Predictors of S-1, Cisplatin, and Docetaxel Combination Chemotherapy for Metastatic Gastric Cancer: Microarray Analysis of Whole Human Genes

By  

Oncology, Vol. 93, Iss. 2, 2017-05 ,pp. : 127-135

Karger

Access to resources Recommend Favorite